4:12 PM Abstract No. 379 Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment

著录项

• 来源
  《Journal of vascular and interventional radiology: JVIR》 |2018年第4suppla期|共2页
• 作者

  Guohong Han; Philippe Merle; Alessandro Granito; Yi-Hsiang Huang; Gy?rgy Bodoky; Osamu Yokosuka; Olivier Rosmorduc; Valeriy Breder; René Gerolami; Gianluca Masi; Paul J. Ross; Shukui Qin; Tianqiang Song; Jean-Pierre Bronowicki; Isabelle Ollivier-Hourmand; Masatoshi Kudo; Marie-Aude LeBerre; Annette Baumhauer; Gerold Meinhardt; Jordi Bruix; RESORCE Investigators;

  展开▼
• 作者单位

  Department of Liver Disease and Digestive Interventional Radiology National Clinical Research;

  Groupement Hospitalier Lyon Nord Hepatology Unit;

  Department of Medical and Surgical Sciences University of Bologna S. Orsola-Malpighi Hospital;

  Division of Gastroenterology and Hepatology Taipei Veterans General Hospital;

  St Laszlo Teaching Hospital;

  Department of Gastroenterology and Nephrology Chiba University;

  Department of Hepatology H?pital de la Pitié-Salpétrière Assistance Publique-H?pitaux de Paris;

  Russian Cancer Research Center n.a.N.Blokhin;

  CHU Timone Université de la Méditerranée;

  Azienda Ospedaliero-Universitaria Pisana;

  King’s College Hospital NHS Foundation Trust;

  Chinese People’s Liberation Army Cancer Center of Nanjing Bayi Hospital;

  Tianjin Medical University Cancer Hospital;

  INSERM 954 CHU de Nancy Université de Lorraine;

  Service d’Hépatogastroentérologie CHU;

  Kindai University Faculty of Medicine;

  Bayer HealthCare SAS;

  Bayer Pharmaceuticals Bayer Vital GmbH;

  Bayer HealthCare Pharmaceuticals;

  BCLC Group Liver Unit Hospital Clinic University of Barcelona CIBEREHD IDIBAPS;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 放射医学;
• 关键词

• 入库时间 2022-08-20 10:26:34